A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Conditions: Overweight Subjects; Obese Subjects Interventions: Drug: metformin; Drug: digoxin; Drug: IBI362; Drug: warfarin; Drug: atorvastatin Sponsor: Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atorvastatin Calcium | Coumadin | Eating Disorders & Weight Management | Fortamet | Lipitor | Metformin | Obesity | Research | Statin Therapy | Study | Warfarin | Zivast